merck kgaa threshold drug fails in late stage cancer trials : Mon, 07 Dec 2015 06:32:02 GMT - FRANKFURT, Dec 7 (Reuters) - Germany's Merck KGaA and development partner Threshold Pharmaceuticals said their experimental cancer drug evofosfamide failed to show the desired effects in two late stage studies.
Readmore …